Nature Communications (Jun 2022)

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

  • Benjamin A. Nacev,
  • Francisco Sanchez-Vega,
  • Shaleigh A. Smith,
  • Cristina R. Antonescu,
  • Evan Rosenbaum,
  • Hongyu Shi,
  • Cerise Tang,
  • Nicholas D. Socci,
  • Satshil Rana,
  • Rodrigo Gularte-Mérida,
  • Ahmet Zehir,
  • Mrinal M. Gounder,
  • Timothy G. Bowler,
  • Anisha Luthra,
  • Bhumika Jadeja,
  • Azusa Okada,
  • Jonathan A. Strong,
  • Jake Stoller,
  • Jason E. Chan,
  • Ping Chi,
  • Sandra P. D’Angelo,
  • Mark A. Dickson,
  • Ciara M. Kelly,
  • Mary Louise Keohan,
  • Sujana Movva,
  • Katherine Thornton,
  • Paul A. Meyers,
  • Leonard H. Wexler,
  • Emily K. Slotkin,
  • Julia L. Glade Bender,
  • Neerav N. Shukla,
  • Martee L. Hensley,
  • John H. Healey,
  • Michael P. La Quaglia,
  • Kaled M. Alektiar,
  • Aimee M. Crago,
  • Sam S. Yoon,
  • Brian R. Untch,
  • Sarah Chiang,
  • Narasimhan P. Agaram,
  • Meera R. Hameed,
  • Michael F. Berger,
  • David B. Solit,
  • Nikolaus Schultz,
  • Marc Ladanyi,
  • Samuel Singer,
  • William D. Tap

DOI
https://doi.org/10.1038/s41467-022-30453-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Sarcomas are rare tumours with many different subtypes and clinical outcomes; a broader knowledge of their genetic features is required. Here, the authors analyse 2138 soft tissue and bone sarcomas across 45 subtypes using MSK-IMPACT targeted sequencing and find genomic groups that are distinct from histological subgroups.